Global Bempedoic Acid API Market Research Report 2022

Global Bempedoic Acid API Market Research Report 2022

Since Esperion launched Bempedoic Acid products in 2019, API manufacturers have gradually participated in the manufacture of Bempedoic Acid products. However, due to patent restrictions, the output of each company has not reached commercial production during the patent period, and except for patent manufacturers, the rest of API companies Most of Bempedoic Acid is only used for scientific research and has not formed commercial application. (The data range of this report is 2020-2028)

Due to the COVID-19 pandemic, the global Bempedoic Acid API market size is estimated to be worth US$ 57.9 million in 2022 and is forecast to a readjusted size of US$ 177.3 million by 2028 with a CAGR of 22.2% during the review period. Fully considering the economic change by this health crisis, 98% accounting for 19.73% of the Bempedoic Acid API global market in 2021, is projected to value US$ 29.1 million by 2028, growing at a revised 18.2% CAGR in the post-COVID-19 period. While Pharmaceutical Manufacturing segment is altered to an 22.8 % CAGR throughout this forecast period.

North America Bempedoic Acid API market is estimated at US$ 39.51 million in 2021, while Europe is forecast to reach US$ 3.9 million by 2028. The proportion of the North America is 76.9% in 2021, while Europe percentage is 7.5%, and it is predicted that Europe share will reach 6.75% in 2028, trailing a CAGR of 20.1 % through the analysis period. As for the Asia, the notable markets are China and India, CAGR is 21.4% % and respectively for the next 6-year period.

The global major manufacturers of Bempedoic Acid API include Esperion, Sun Pharmaceutical, Metrochem API Pvt Ltd, Conscientia Industrial Co., Ltd, Viruj Pharma, Lee Pharma, Optimus Drugs Pvt LTD, Rui Laboratories, and Shanghai Yingrui Biopharma Co., Ltd., etc. In terms of revenue, the global 3 largest players have a 98.14% market share of Bempedoic Acid API in 2021.

Global Bempedoic Acid API Market: Drivers and Restrains

The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2020 to 2028. This section mentions the volume of production by region from 2020 to 2028. Pricing analysis is included in the report according to each type from the year 2020 to 2028, manufacturer from 2020 to 2022, region from 2020 to 2022, and global price from 2020 to 2028.

A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.

Global Bempedoic Acid API Market: Segment Analysis

The research report includes specific segments by region (country), by manufacturers, by Purity and by Application. Each type provides information about the production during the forecast period of 2020 to 2028. by Application segment also provides consumption during the forecast period of 2020 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.


By Company
Esperion
Sun Pharmaceutical
Metrochem API Pvt Ltd
Conscientia Industrial Co., Ltd
Viruj Pharma
Lee Pharma
Optimus Drugs Pvt LTD
Rui Laboratories
Shanghai Yingrui Biopharma Co., Ltd.
China Fortune Way Company
Henan Dongyao Medical Technology Co., Ltd.
Speranza Chemical Co., Ltd.


Segment by Purity
98%
99%
Other


Segment by Application
Pharmaceutical Manufacturing
Scientific Research


Production by Region
North America
Europe
China
India


Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
India
Europe
Germany
France
U.K.
Italy
Rest of Europe